Knockdown transgenic Lrrk Drosophila resists paraquat-induced locomotor impairment and neurodegeneration: A therapeutic strategy for Parkinson’s disease

2017 ◽  
Vol 1657 ◽  
pp. 253-261 ◽  
Author(s):  
Diana Quintero-Espinosa ◽  
Marlene Jimenez-Del-Rio ◽  
Carlos Velez-Pardo
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Therapeutic Strategy ◽  
Locomotor Impairment

scholarly journals Clearing Extracellular Alpha-Synuclein from Cerebrospinal Fluid: A New Therapeutic Strategy in Parkinson’s Disease

2018 ◽  
Vol 8 (4) ◽  
pp. 52 ◽  
Author(s):  
Manuel Menéndez-González ◽  
Huber Padilla-Zambrano ◽  
Cristina Tomás-Zapico ◽  
Benjamin García
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Cerebrospinal Fluid ◽  
Therapeutic Strategy ◽  
Alpha Synuclein

scholarly journals RNA knockdown as a potential therapeutic strategy in Parkinson's disease

Gene Therapy ◽  
2005 ◽  
Vol 13 (6) ◽  
pp. 517-524 ◽  
Author(s):  
F P Manfredsson ◽  
A S Lewin ◽  
R J Mandel
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Therapeutic Strategy ◽  
Rna Knockdown

Activating Autophagy as a Therapeutic Strategy for Parkinson’s Disease

CNS Drugs ◽  
2018 ◽  
Vol 32 (1) ◽  
pp. 1-11 ◽  
Author(s):  
Alan J. Fowler ◽  
Charbel E.-H. Moussa
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Therapeutic Strategy

Targeting α-synuclein as a therapeutic strategy for Parkinson’s disease

2015 ◽  
Vol 19 (10) ◽  
pp. 1351-1360 ◽  
Author(s):  
Nada B Lawand ◽  
Nayef E Saadé ◽  
Omar M El-Agnaf ◽  
Bared Safieh-Garabedian
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Therapeutic Strategy
Sign in / Sign up

Export Citation Format

Share Document